ライフサイエンスコーパス: bacterial vaginosis

1 althy microbiota, 4-6 intermediate, and 7-10 bacterial vaginosis).

2 la vaginalis (one of the causative agents of bacterial vaginosis).

3 tcome data in women who are asymptomatic for bacterial vaginosis.

4 in 3 months before enrollment, 131 (39%) had bacterial vaginosis.

5 and treating asymptomatic pregnant women for bacterial vaginosis.

6 or average-risk pregnancies for asymptomatic bacterial vaginosis.

7 microbiological constituents responsible for bacterial vaginosis.

8 ne were associated with an increased risk of bacterial vaginosis.

9 lammatory-cytokine expression in response to bacterial vaginosis.

10 O(2)-producing lactobacilli among women with bacterial vaginosis.

11 ridiales order that were highly specific for bacterial vaginosis.

12 smitted-disease acquisition among women with bacterial vaginosis.

13 and, in females, incident trichomoniasis and bacterial vaginosis.

14 elopment as a probiotic for the treatment of bacterial vaginosis.

15 a vulvovaginitis, Trichomonas vaginitis, and bacterial vaginosis.

16 ffect of N-9 use on vaginal lactobacilli and bacterial vaginosis.

17 rt of ongoing studies on the pathogenesis of bacterial vaginosis.

18 ty to sexually transmitted infections during bacterial vaginosis.

19 antimicrobial agent used in the treatment of bacterial vaginosis.

20 diate Nugent scores but not among women with bacterial vaginosis.

21 Gardnerella vaginalis predominates in bacterial vaginosis.

22 ic STIs, compared with women with no STIs or bacterial vaginosis.

23 associated with presumed bacterial agents of Bacterial vaginosis.

24 esized to play a role in the pathogenesis of bacterial vaginosis.

25 ch are used as a factor for the diagnosis of bacterial vaginosis.

26 response to vaginal symptoms associated with bacterial vaginosis.

27 y visits, 40.2% were classified as involving bacterial vaginosis.

28 tion: ovarian cancer (4 studies; n = 26432), bacterial vaginosis (2 studies; n = 930), trichomoniasis

29 , T vaginalis, 17.8% (12.4%-23.1%; n = 822), bacterial vaginosis, 37.6% (18.0%-57.2%; n = 1208), peri

30 T vaginalis, 29.1% (20.9%-37.2%; n = 5502), bacterial vaginosis, 50.8% (43.3%-58.4%; n = 4280), peri

31 Bacterial vaginosis, a common disorder among young women

32 ne interleukin-8 (IL-8) was not increased in bacterial vaginosis, accounting for low concentrations o

33 Bacterial vaginosis affects millions of women and is ass

34 The prevalence of bacterial vaginosis among lesbians is high.

35 lis isolates analyzed, 10 from patients with bacterial vaginosis and 10 from patients without bacteri

36 ectly on vaginal fluid from 27 subjects with bacterial vaginosis and 46 without the condition.

37 re warranted, since prevention strategies of bacterial vaginosis and colonization by certain biotypes

38 ively associated with M. genitalium, whereas bacterial vaginosis and cunnilingus were negatively asso

39 bean, and other black (ACB) women, including bacterial vaginosis and herpes simplex virus type-2 (HSV

40 mong African women with a high prevalence of bacterial vaginosis and high adherence to PrEP, the effi

41 ations of antimicrobial polypeptides in both bacterial vaginosis and in vulvovaginal candidiasis, sug

42 udies found no association between confirmed bacterial vaginosis and MHM (OR: 1.07, 95% CI: 0.52-2.24

43 view summarizes our current understanding of bacterial vaginosis and where future research should be

44 pregnant and 99 nonpregnant women, all with bacterial vaginosis and without concurrent sexually tran

45 , and it reduces HPV, genital ulcer disease, bacterial vaginosis, and trichomoniasis among female par

46 h vaginitis, vaginal discharge, candidiasis, bacterial vaginosis, and trichomoniasis.

47 of the transmitter (i.e., male circumcision, bacterial vaginosis, and use of acyclovir) explained 46%

48 traditionally diagnosed vaginal candidiasis, bacterial vaginosis, and vaginal trichomoniasis using so

49 After excluding women with concurrent bacterial vaginosis, another possible cause of vaginal s

50 Abnormal vaginal flora and bacterial vaginosis are associated with amplified risks

51 Currently recommended treatment options for bacterial vaginosis are associated with high rates of re

52 at <35 weeks and 2) body mass index <19.8 or bacterial vaginosis as assessed by Gram stain.

53 obstetrical population who have asymptomatic bacterial vaginosis (as diagnosed on the basis of vagina

54 vide the best evidence to date for a risk of bacterial vaginosis associated with douching.

55 Resistance to clindamycin by bacterial vaginosis-associated anaerobic organisms has a

56 The role of newly defined bacterial vaginosis-associated bacteria (BVAB), which ha

57 are emerging regarding the potential role of bacterial vaginosis-associated bacteria in urethritis, a

58 elicited by colonization with commensal and bacterial vaginosis-associated bacteria.

59 vel taxa (including increased frequencies of bacterial vaginosis-associated bacterium 1 [BVAB1], BVAB

60 bacterial vaginosis (BV)--Atopobium vaginae, Bacterial Vaginosis-Associated Bacterium 2 (BVAB-2), Gar

61 ve PCR for the presence and concentration of bacterial vaginosis-associated microbes and commensal La

62 0 women (median age 33 years), 357 (24%) had bacterial vaginosis at enrolment.

63 tus) or 2 prevalent bacteria associated with bacterial vaginosis (Atopobium vaginae and Prevotella bi

64 ribed were highly prevalent in subjects with bacterial vaginosis but rare in healthy controls.

65 Bacterial vaginosis (BV) affects almost a quarter of US

66 ntly found a significant association between bacterial vaginosis (BV) and acquisition of sexually tra

67 We assessed the association between recent bacterial vaginosis (BV) and incident Mycoplasma genital

68 nalis is a bacterial species associated with bacterial vaginosis (BV) and its significant adverse seq

69 ontroversy surrounds the association between bacterial vaginosis (BV) and pelvic inflammatory disease

70 en implicated in vaginal infections, notably bacterial vaginosis (BV) and vulvovaginal candidiasis (V

71 V prevalence, sexual behavior, and suspected bacterial vaginosis (BV) as defined by Nugent Gram stain

72 ically described as normal, intermediate, or bacterial vaginosis (BV) as defined by Nugent's criteria

73 We sought to assess the relationship between bacterial vaginosis (BV) assessed by Gram stain and inci

74 udy the pathogenesis and transmissibility of bacterial vaginosis (BV) because it can be diagnosed in

75 of vaginal microbes isolated from women with bacterial vaginosis (BV) before and after therapy, 119 n

76 species have been detected in subjects with bacterial vaginosis (BV) by using broad-range PCR assays

77 ) infected women have a higher prevalence of bacterial vaginosis (BV) compared to HSV-2-seronegative

78 Women with bacterial vaginosis (BV) display reduced vaginal acidity

79 Women with bacterial vaginosis (BV) have complex communities of ana

80 ith sexually transmitted diseases (STDs) and bacterial vaginosis (BV) have increased rates of cytomeg

81 Bacterial vaginosis (BV) in pregnancy is linked to prete

82 Bacterial vaginosis (BV) is a clinical syndrome presenti

83 Bacterial vaginosis (BV) is a common clinical syndrome i

84 Bacterial vaginosis (BV) is a common disorder characteri

85 Bacterial vaginosis (BV) is a common polymicrobial disea

86 Bacterial vaginosis (BV) is a common polymicrobial imbal

87 Bacterial vaginosis (BV) is a perturbation of vaginal fl

88 Bacterial vaginosis (BV) is a polymicrobial imbalance of

89 Bacterial vaginosis (BV) is associated with an increased

90 Bacterial vaginosis (BV) is associated with complication

91 Bacterial vaginosis (BV) is associated with human immuno

92 Bacterial vaginosis (BV) is associated with increased ri

93 Bacterial vaginosis (BV) is characterized by dramatic ch

94 Bacterial vaginosis (BV) is characterized by low abundan

95 "gold standard" method for the diagnosis of bacterial vaginosis (BV) is lacking.

96 Bacterial vaginosis (BV) is one of the most common cause

97 Bacterial vaginosis (BV) is the most common cause of vag

98 Bacterial vaginosis (BV) is the most common gynecologica

99 Bacterial vaginosis (BV) is the worldwide leading vagina

100 Bacterial vaginosis (BV) may be common among women who r

101 at specific vaginal bacteria associated with bacterial vaginosis (BV) may increase the risk of advers

102 Bacterial vaginosis (BV) may increase women's susceptibi

103 apillomavirus (HPV) infection is affected by bacterial vaginosis (BV) or Trichomonas vaginalis (TV) i

104 Bacterial vaginosis (BV) recurrence posttreatment is com

105 Bacterial vaginosis (BV) represents shifts in microbiota

106 astidious bacteria have been associated with bacterial vaginosis (BV) using broad-range bacterial PCR

107 e-resistant anaerobe, Atopobium vaginae, and bacterial vaginosis (BV) warrants further investigation.

108 m, Mycoplasma hominis, and Candida albicans; bacterial vaginosis (BV) was identified by clinical crit

109 Bacterial vaginosis (BV) was identified recently as a co

110 During a 2-year follow-up, 50 women acquired bacterial vaginosis (BV), 25 acquired symptomatic vulvov

111 Bacterial vaginosis (BV), a disruption of the normal vag

112 ween vaginal colonization with lactobacilli, bacterial vaginosis (BV), and acquisition of human immun

113 SW) was performed to determine the burden of bacterial vaginosis (BV), and behavioral factors influen

114 umber of lifetime sexual partners, syphilis, bacterial vaginosis (BV), and vaginal candidiasis.

115 or L. jensenii vaginally and/or rectally had bacterial vaginosis (BV), compared with 12 (44%) of 27 f

116 Despite the worldwide prevalence of bacterial vaginosis (BV), its etiology is still unknown.

117 Cervicitis commonly occurs in women with bacterial vaginosis (BV), often without concomitant chla

118 ies most frequently isolated from women with bacterial vaginosis (BV), produces a cholesterol-depende

119 ghts of the expert technical consultation on bacterial vaginosis (BV), sponsored by the National Inst

120 During bacterial vaginosis (BV), there is a loss of vaginal aci

121 The primary end points were bacterial vaginosis (BV), vaginal candidiasis, trichomon

122 with 1 or more vaginal infections, including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC)

123 hosted an experts technical consultation on bacterial vaginosis (BV), where data regarding controver

124 ful positive indicators for the diagnosis of bacterial vaginosis (BV)--Atopobium vaginae, Bacterial V

125 t therapeutic approaches to the treatment of bacterial vaginosis (BV).

126 aginalis is the most common species found in bacterial vaginosis (BV).

127 hemical alterations induced by pregnancy and bacterial vaginosis (BV).

128 HIV-negative (HIV(-)) women with or without bacterial vaginosis (BV).

129 extreme genital inflammation and persistent bacterial vaginosis (BV); this subtype could be predicte

130 avaginalis test were compared with a unified bacterial-vaginosis (BV) reference standard incorporatin

131 primary or recurrent genital herpes, having bacterial vaginosis by Nugent criteria, and having had t

132 ivity (100%) but a low specificity (zero for bacterial vaginosis, candida, and Trichomonas vaginalis)

133 Samples for detection of bacterial vaginosis, Chlamydia trachomatis, and Neisseri

134 he cervix is enhanced in pregnant women with bacterial vaginosis, compared with that in nonpregnant w

135 that racial differences persist for rates of bacterial vaginosis even when other known risk factors a

136 ferences and why some but not all women with bacterial vaginosis experience complications.

137 PCR was used to survey bacterial vaginosis flora before and after metronidazole

138 Bacterial vaginosis frequently persists after treatment.

139 viral concentrations, menstrual cycle phase, bacterial vaginosis, genital bleeding, or plasma virus d

140 the follow-up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chlamydia infection

141 Among women with bacterial vaginosis, H(2)O(2)-producing lactobacillus co

142 Women without bacterial vaginosis had 1 to 6 vaginal bacterial species

143 Women with bacterial vaginosis had greater bacterial diversity (P<0

144 Bacterial vaginosis has been associated with preterm bir

145 e rapid point-of-care diagnostic testing for bacterial vaginosis has emerged.

146 Women with bacterial vaginosis have complex vaginal infections with

147 Women with bacterial vaginosis have different microbiological profi

148 fficacy 62.72% [95% CI -66.59 to 91.66]), or bacterial vaginosis (HIV incidence 0.9 per 100 person-ye

149 or individual physical examination findings (bacterial vaginosis, homogeneous discharge: sensitivity

150 ere baseline chlamydial infection (HR, 5.2), bacterial vaginosis (HR, 2.1), and the occurrence of gen

151 hing has been reported to be associated with bacterial vaginosis in observational studies.

152 to prevent preterm birth by the treatment of bacterial vaginosis in pregnancy are disappointing.

153 ghed the benefits and harms of screening for bacterial vaginosis in pregnancy by identifying new evid

154 rce (USPSTF) recommendation on screening for bacterial vaginosis in pregnancy.

155 lance of benefits and harms of screening for bacterial vaginosis in pregnant women at high risk for p

156 Do not screen for bacterial vaginosis in pregnant women at low risk for pr

157 The treatment of asymptomatic bacterial vaginosis in pregnant women does not reduce th

158 In clinical trials, the treatment of bacterial vaginosis in pregnant women who previously had

159 lis infection, vulvovaginal candidiasis, and bacterial vaginosis) in HIV-1-seropositive versus HIV-1-

160 smears to diagnose abnormal vaginal flora or bacterial vaginosis, in accordance with Nugent's criteri

161 cterial phylotypes and those associated with bacterial vaginosis, including Atopobium vaginae, were i

162 rial species were detected in the women with bacterial vaginosis, including several species with no c

163 Bacterial vaginosis increases the susceptibility to sexu

164 Bacterial vaginosis is a common condition associated wit

165 Bacterial vaginosis is a highly prevalent and poorly und

166 Bacterial vaginosis is a risk factor for preterm birth.

167 Persistent bacterial vaginosis is associated with several bacteria

168 nd that vaginal lavage fluid from women with bacterial vaginosis is deficient in antimicrobial polype

169 Bacterial vaginosis is far more than a nuisance infectio

170 Bacterial vaginosis is the most common lower genital tra

171 Bacterial vaginosis is the most common vaginal condition

172 Bacterial vaginosis is the most common vaginal disorder

173 he loss of normal immunostimulatory flora in bacterial vaginosis is thus associated with a local defi

174 ho have sex only with men, or to women whose bacterial vaginosis is treated with oral antibiotics.

175 The etiology of bacterial vaginosis is unknown, and there are no long-te

176 cheese" odor on examination is predictive of bacterial vaginosis (LR, 3.2 [95% CI, 2.1-4.7]) while la

177 We investigated whether bacterial vaginosis modified the efficacy of oral PrEP.

178 For bacterial vaginosis (n=73), neither the shedding of HIV-

179 erial vaginosis and 10 from patients without bacterial vaginosis, none shared the same DNA fingerprin

180 Women (N = 40) with incident bacterial vaginosis (Nugent 7-10) had significantly lowe

181 tic device, the Osmetech Microbial Analyzer--Bacterial Vaginosis (OMA-BV), which determines a patient

182 2-22 weeks' gestation (mean 15.6 weeks)--for bacterial vaginosis or abnormal vaginal flora.

183 either before labor for risk factors such as bacterial vaginosis or during preterm labor have not con

184 without the need for concurrent testing for bacterial vaginosis or vaginal dysbiosis.

185 ptive usage (P=.008), and lower frequency of bacterial vaginosis (P<.001) and gonorrhea (P=.03).

186 o determine whether prevention or control of bacterial vaginosis, particularly approaches that rely n

187 al human beta-defensin-2 mRNA, but a typical bacterial vaginosis pathogen, Gardnerella vaginalis, had

188 The cause of bacterial vaginosis remains poorly understood despite nu

189 Bacterial vaginosis represents a unique upheaval of the

190 Bacterial vaginosis resolved in 657 of 845 women who had

191 digital-vaginal sex (P = .04) and increased bacterial vaginosis risk (odds ratio, 4.2; 95% confidenc

192 to estimate the causal effect of douching on bacterial vaginosis risk while controlling for this conf

193 of N-9 for 2 weeks reduced the likelihood of bacterial vaginosis (RR, 0.5; 95% CI, 0.3-1.0).

194 efficacy among subgroups of women defined by bacterial vaginosis status based on yearly microscopy an

195 eria gonorrhoeae, Trichomonas vaginalis, and bacterial vaginosis testing were collected from female a

196 potential nonantibiotic adjunct to existing bacterial vaginosis therapies in order to decrease the r

197 or helpful, and to explore the relevance of bacterial vaginosis to other adverse pregnancy outcomes,

198 eatment guidelines for gonorrhea, chlamydia, bacterial vaginosis, trichomonas, vulvovaginal candidias

199 Each diagnostic accuracy study for bacterial vaginosis, trichomoniasis, and genital herpes

200 0.72-0.87]) and lack of perceived odor makes bacterial vaginosis unlikely (LR, 0.07 [95% CI, 0.01-0.5

201 is and Neisseria gonorrhoeae using NAATs and bacterial vaginosis using Gram stains.

202 d for follow-up, the incidence of persistent bacterial vaginosis was 26% and was statistically signif

203 Bacterial vaginosis was associated with fewer episodes o

204 Bacterial vaginosis was based on a Nugent's Gram stain s

205 Bacterial vaginosis was treated with intravaginal metron

206 res categorized as normal, intermediate, and bacterial vaginosis were included.

207 nsmission is integral to the pathogenesis of bacterial vaginosis, which has substantial implications

208 d a retrospective analysis of 947 women with bacterial vaginosis who were enrolled in prospective stu

209 t of asymptomatic abnormal vaginal flora and bacterial vaginosis with oral clindamycin early in the s